Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 06/05/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/05/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/02/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/02/17 | 8-K | Current report filing |
|
42 | |
| 04/24/17 | CT ORDER | Confidential treatment order |
|
1 | |
| 04/17/17 | 8-K | Current report filing |
|
7 | |
| 04/13/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
70 |
| 04/12/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 04/12/17 | 3 | Initial statement of beneficial ownership of securities |
|
3 | |
| 04/11/17 | 8-K | Current report filing |
|
7 |
